Sponsor

Cerevance Beta Inc.

United States 1 Marina Park Drive Suite 1410, 02210-1874, United States

About the sponsor

Cerevance Beta Inc. focuses on clinical research in Parkinson disease, with attention to motor symptom control and day-to-day functional impairment.

Parkinson disease
OFF time
Motor fluctuations

The sponsor’s active trial portfolio is centered on treatments intended to address symptom variability in Parkinson disease and related movement-disorder burden.

About Specializations

Cerevance Beta Inc. runs clinical trials in conditions such as Parkinson's disease, among others.

Parkinson's disease

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Parkinson's disease

Not recruiting

Investigational

Study of CVN424 for Reducing Motor Complications in Parkinson's Disease Patients

Investigational

Czechia

Participants:18–64 years · 65+ years
Substances:1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
Sponsor:Cerevance Beta Inc.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →